Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
about
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsTobacco smoke is a source of toxic reactive glycation productsOrally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyHow hyperglycemia promotes atherosclerosis: molecular mechanisms.Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementOral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humansAdvanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry.Diabetes and mass spectrometry.Advanced glycation end products/peptides: an in vivo investigation.Tissue-advanced glycation end product concentration in dialysis patients.Glycemic control and cardiovascular disease in type 2 diabetes: a review.Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidineBlockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.The AGE-receptor in the pathogenesis of diabetic complications.Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.Endothelial dysfunction in children with type 1 diabetes mellitus.Free radicals, diabetes and endothelial dysfunction.Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.Molecular mechanisms of diabetic cardiovascular disease.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentPreventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control.Microvascular disease aetiology in diabetic foot ulceration.Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.Dietary advanced glycation end products and aging.Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo.Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamsterAdvanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patientsThe challenge of type 1 diabetes mellitus.Role of advanced glycation end products in cardiovascular disease.Advanced glycation end products induce glomerular sclerosis and albuminuria in normal ratsRelationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal WomenGlycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisHyperglycemia, lipoprotein glycation, and vascular disease.Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.LDL biochemical modifications: a link between atherosclerosis and aging.
P2860
Q24561776-A745B781-91FE-4D36-9611-08055A7180B6Q24623337-F066ACC0-5BFC-4942-BB48-2F6F484B04ACQ24682750-D1203728-BE82-40FF-BE7B-5BACAB3C37D3Q24795988-92600CDC-B8E7-4727-A35B-5539301889DEQ26781156-1DF9D559-8374-43A3-91D1-687AFE85EE30Q30575530-D115FCBB-81A4-4C41-BB28-5C52F5C6EDB4Q30665222-41CF5BB3-2507-46CE-83C5-689F4DF41AFCQ30986952-B86EDC24-DA36-4D92-B12E-22589E5CB417Q33220106-ECA63458-AE6E-4866-9415-58AF3366D350Q33571288-6A6832BA-FA97-4C59-890E-535277D388F9Q33707377-AA037F0D-1C01-483E-8B82-DE52829A8B9FQ33922502-793D5896-712D-43CA-8310-DF8C1417F27DQ33998524-F79E8E17-77D6-4792-9275-A32707369C67Q34374197-E1B8F0DB-380F-4567-B5E3-CB6B7C31B00AQ34432623-4D90C324-BB3E-40A7-9F2D-3B4E0A9E800AQ34470639-3C566ABF-A7ED-4B14-BE4F-7945C7D4399AQ34481838-DFB6D537-1038-4316-B1F5-BCA68054FAB0Q34572620-99831CDD-FC06-44AE-B041-372E6A1B6933Q34636106-8438F50A-412D-4BAF-B2BA-27E9767B7FD1Q34722600-050C0DA6-EA8A-4363-B6AB-4A3A534ABF7AQ34885399-6CA539E9-5D1F-4A08-B872-561D11A56171Q34989681-AA545D78-CBBB-48A4-B36D-A5027190EF5CQ35029623-35E77E36-9DA1-43AA-BD1A-50B0148EAA3CQ35095210-0ABCED95-4F45-47AA-9892-C39B001EB3DDQ35215300-8724039E-550A-4301-89EF-47C2AD3E5973Q35576119-464ED143-D70E-4A79-BAD2-4E13A6B7DD8BQ35670859-A4E570E8-AC5E-44F7-B466-7B79E7F113EFQ35690158-AB605D1A-8175-449E-9DCE-23406572B5D3Q35747582-880FD809-0A89-4E2C-8086-3469B634233AQ35774329-A5235D68-A6B8-4138-993C-4EC09B68DF14Q35800420-62B1765B-5FA0-4D01-B5BB-9C6A84771097Q35823958-042B580E-8CF2-4443-955E-A851D80DAA87Q35929112-F10A33C6-87C6-4263-971F-1BF883B37A6DQ35931294-22D1D345-11CD-4808-98BD-81970FF96146Q36047141-D55D072C-0FC3-49D1-8A87-27D81B88F25CQ36052417-2027CBB8-5DB9-49E5-B113-C8EA98DE9618Q36218217-87BCC5FB-EF09-4902-870F-FE240FC04B2EQ36300685-0E66C79D-FB4D-4D90-A5E0-4334CEDD74A7Q36318280-15DD6069-BF95-48DC-848E-7EED14C0638DQ36348442-3EB5B4FB-DFED-45E3-A499-6B67DEBC0472
P2860
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Modification of low density li ...... betes and renal insufficiency.
@ast
Modification of low density li ...... betes and renal insufficiency.
@en
type
label
Modification of low density li ...... betes and renal insufficiency.
@ast
Modification of low density li ...... betes and renal insufficiency.
@en
prefLabel
Modification of low density li ...... betes and renal insufficiency.
@ast
Modification of low density li ...... betes and renal insufficiency.
@en
P2093
P2860
P356
P1476
Modification of low density li ...... betes and renal insufficiency.
@en
P2093
H Vlassara
T Koschinsky
P2860
P304
P356
10.1073/PNAS.91.20.9441
P407
P577
1994-09-01T00:00:00Z